This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1978 Jul;96(1):97-109.

doi: 10.1016/0002-8703(78)90132-1.

The treatment of low-renin ("primary") hyperaldosteronism

J B Ferriss, D G Beevers, K Boddy, J J Brown, D L Davies, R Fraser, D Kremer, A F Lever, J I Robertson

PMID: 655118
DOI: 10.1016/0002-8703(78)90132-1

The treatment of low-renin ("primary") hyperaldosteronism

J B Ferriss et al. Am Heart J. 1978 Jul.

. 1978 Jul;96(1):97-109.

doi: 10.1016/0002-8703(78)90132-1.

Authors

J B Ferriss, D G Beevers, K Boddy, J J Brown, D L Davies, R Fraser, D Kremer, A F Lever, J I Robertson

PMID: 655118
DOI: 10.1016/0002-8703(78)90132-1

No abstract available

PubMed Disclaimer

Similar articles

Spironolactone and amiloride in hypertensive patients with and without aldosterone excess.
Hoefnagels WH, Drayer JI, Smals AG, Kloppenborg PW. Hoefnagels WH, et al. Clin Pharmacol Ther. 1980 Mar;27(3):317-23. doi: 10.1038/clpt.1980.42. Clin Pharmacol Ther. 1980. PMID: 6987022 No abstract available.
[Primary hyperaldosteronism].
Plouin PF, Massien-Simon C. Plouin PF, et al. Rev Prat. 1998 Apr 1;48(7):749-53. Rev Prat. 1998. PMID: 11767370 Review. French.
[Primary hyperaldosteronism: boundaries of diagnostics and therapy].
Riester A, Reincke M, Beuschlein F. Riester A, et al. Dtsch Med Wochenschr. 2014 Oct;139(40):1982-4. doi: 10.1055/s-0034-1370282. Epub 2014 Sep 25. Dtsch Med Wochenschr. 2014. PMID: 25254391 Review. German. No abstract available.
Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
Kremer D, Beevers DG, Brown JJ, Davies DL, Ferriss JB, Fraser R, Lever AF, Robertson JI. Kremer D, et al. Clin Sci Mol Med Suppl. 1973 Aug;45 Suppl 1:213s-8. doi: 10.1042/cs045213s. Clin Sci Mol Med Suppl. 1973. PMID: 4361398 No abstract available.
[Therapy of adrenal cortex diseases].
von Werder K. von Werder K. Dtsch Med Wochenschr. 1998 Apr 3;123(14):429-31. doi: 10.1055/s-2007-1023982. Dtsch Med Wochenschr. 1998. PMID: 9581170 Review. German. No abstract available.

See all similar articles

Cited by

[Modern pharmacological aspects of hyperaldosteronism therapy].
Quinkler M, Reincke M. Quinkler M, et al. Internist (Berl). 2006 Sep;47(9):953-9. doi: 10.1007/s00108-006-1681-0. Internist (Berl). 2006. PMID: 16823578 Review. German.
Hormones other than aldosterone may contribute to hypertension in 3 different subtypes of primary aldosteronism.
Ye F, Tang ZY, Wu JC, Yang Y, Tian XL, Huang JJ, Zhang SS, Ning G. Ye F, et al. J Clin Hypertens (Greenwich). 2013 Apr;15(4):264-9. doi: 10.1111/jch.12070. Epub 2013 Feb 27. J Clin Hypertens (Greenwich). 2013. PMID: 23551726 Free PMC article.
ENaC inhibition stimulates Cl- secretion in the mouse cortical collecting duct through an NKCC1-dependent mechanism.
Pech V, Thumova M, Kim YH, Agazatian D, Hummler E, Rossier BC, Weinstein AM, Nanami M, Wall SM. Pech V, et al. Am J Physiol Renal Physiol. 2012 Jul 1;303(1):F45-55. doi: 10.1152/ajprenal.00030.2012. Epub 2012 Apr 11. Am J Physiol Renal Physiol. 2012. PMID: 22496413 Free PMC article.
Malignant hypertension and asymmetric septal hypertrophy in a 43-year-old black man.
Rutledge JC, Eng A, Silva J Jr. Rutledge JC, et al. West J Med. 1986 Sep;145(3):356-61. West J Med. 1986. PMID: 3765616 Free PMC article. No abstract available.
Clinical significance of associated nodular lesions of the adrenal in patients with aldosteronoma.
Ito Y, Fujimoto Y, Obara T, Kodama T. Ito Y, et al. World J Surg. 1990 May-Jun;14(3):330-4. doi: 10.1007/BF01658518. World J Surg. 1990. PMID: 2368435

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science